Holen Sie sich die Stockscreener-App
22.03
1.39%
-0.31
Handel nachbörslich:
22.54
0.51
+2.32%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt ARWR?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$22.34
Offen:
$22.43
24-Stunden-Volumen:
2.27M
Relative Volume:
1.15
Marktkapitalisierung:
$3.05B
Einnahmen:
$181.74M
Nettoeinkommen (Verlust:
$-143.97M
KGV:
-15.85
EPS:
-1.39
Netto-Cashflow:
$9.60M
1W Leistung:
+3.28%
1M Leistung:
+38.38%
6M Leistung:
+16.31%
1J Leistung:
-8.51%
1-Tages-Spanne:
$21.61
$22.55
1-Wochen-Bereich:
$20.45
$22.75
52-Wochen-Spanne:
$9.57
$27.34
Arrowhead Pharmaceuticals Inc Stock (ARWR) Company Profile
Firmenname
Arrowhead Pharmaceuticals Inc
Sektor
Branche
Telefon
626-696-4702
Adresse
177 E COLORADO BLVD, PASADENA, CA
Vergleichen Sie ARWR mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ARWR
Arrowhead Pharmaceuticals Inc
|
22.03 | 3.09B | 181.74M | -143.97M | 9.60M | -1.39 |
|
VRTX
Vertex Pharmaceuticals Inc
|
391.02 | 100.52B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
580.70 | 61.43B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
446.51 | 59.29B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
712.20 | 43.09B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
306.05 | 35.42B | 3.81B | -644.79M | -669.77M | -6.24 |
Arrowhead Pharmaceuticals Inc Stock (ARWR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-06-05 | Eingeleitet | Goldman | Neutral |
| 2023-12-04 | Eingeleitet | BofA Securities | Buy |
| 2023-09-19 | Eingeleitet | Citigroup | Neutral |
| 2023-07-21 | Eingeleitet | TD Cowen | Outperform |
| 2023-05-12 | Herabstufung | SVB Securities | Outperform → Market Perform |
| 2023-04-26 | Eingeleitet | SMBC Nikko | Outperform |
| 2023-04-12 | Hochstufung | SVB Securities | Market Perform → Outperform |
| 2023-03-21 | Eingeleitet | Bernstein | Mkt Perform |
| 2022-09-09 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2022-05-11 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2022-01-19 | Fortgesetzt | Goldman | Buy |
| 2021-08-06 | Bestätigt | Chardan Capital Markets | Buy |
| 2021-06-04 | Fortgesetzt | Robert W. Baird | Neutral |
| 2021-02-05 | Bestätigt | H.C. Wainwright | Buy |
| 2020-12-21 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2020-12-16 | Eingeleitet | UBS | Buy |
| 2020-11-19 | Eingeleitet | Citigroup | Buy |
| 2020-05-13 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2020-05-08 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2020-04-15 | Hochstufung | Cantor Fitzgerald | Neutral → Overweight |
| 2020-03-24 | Hochstufung | SVB Leerink | Underperform → Mkt Perform |
| 2020-03-17 | Eingeleitet | Goldman | Neutral |
| 2020-01-21 | Eingeleitet | SVB Leerink | Underperform |
| 2019-12-13 | Eingeleitet | Oppenheimer | Perform |
| 2019-11-29 | Bestätigt | Chardan Capital Markets | Buy |
| 2019-11-27 | Bestätigt | B. Riley FBR | Buy |
| 2019-11-25 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2019-10-24 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2019-10-22 | Bestätigt | Chardan Capital Markets | Buy |
| 2019-10-03 | Eingeleitet | Robert W. Baird | Outperform |
| 2018-09-07 | Hochstufung | B. Riley FBR | Neutral → Buy |
| 2018-09-06 | Bestätigt | Chardan Capital Markets | Buy |
| 2018-08-08 | Bestätigt | Cantor Fitzgerald | Overweight |
| 2018-07-02 | Bestätigt | Chardan Capital Markets | Buy |
Alle ansehen
Arrowhead Pharmaceuticals Inc Aktie (ARWR) Neueste Nachrichten
Arrowhead Pharmaceuticals Inc. stock momentum explained2025 Fundamental Recap & Safe Swing Trade Setup Alerts - Newser
Volume spikes in Arrowhead Pharmaceuticals Inc. stock – what they meanWeekly Investment Summary & Expert Approved Trade Ideas - Newser
Arrowhead Pharmaceuticals Inc. stock daily chart insightsPortfolio Performance Report & Advanced Swing Trade Entry Alerts - Newser
Institutional Ownership: A Key Indicator for Arrowhead Pharmaceuticals' Stock Performance - AInvest
Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) institutional owners may be pleased with recent gains after 7.6% loss over the past year - Yahoo Finance
Can trapped investors hope for a rebound in Arrowhead Pharmaceuticals Inc.2025 Market WrapUp & Free Risk Controlled Daily Trade Plans - Newser
Is Arrowhead Pharmaceuticals Inc. forming a bottoming base2025 Investor Takeaways & Capital Efficiency Focused Strategies - Newser
Identifying reversal signals in Arrowhead Pharmaceuticals Inc.Weekly Profit Analysis & Technical Buy Zone Confirmations - Newser
Is Arrowhead Pharmaceuticals Inc. stock entering bullish territoryInsider Buying & Reliable Momentum Entry Alerts - Newser
Order flow analysis tools used on Arrowhead Pharmaceuticals Inc.Trade Volume Summary & Weekly High Momentum Picks - Newser
How to use Fibonacci retracement on Arrowhead Pharmaceuticals Inc.2025 Stock Rankings & AI Forecasted Stock Moves - Newser
Can a trend reversal in Arrowhead Pharmaceuticals Inc. lead to recoveryEarnings Growth Summary & Free Community Supported Trade Ideas - Newser
Arrowhead Pharmaceuticals Inc. stock volume spike explainedTrade Entry Report & Weekly Setup with ROI Potential - Newser
Smart tools for monitoring Arrowhead Pharmaceuticals Inc.’s price actionVolume Spike & Daily Momentum Trading Reports - Newser
Is Arrowhead Pharmaceuticals Inc. forming a double bottom getLinesFromResByArray error: size == 0 - 클래시안
Published on: 2025-08-31 13:51:49 - Newser
Will Arrowhead Pharmaceuticals Inc. price bounce be sustainableEarnings Recap Summary & Risk Managed Investment Entry Signals - Newser
Using data models to predict Arrowhead Pharmaceuticals Inc. stock movementOil Prices & High Yield Stock Recommendations - Newser
Why Arrowhead Pharmaceuticals Inc. stock attracts strong analyst attentionPortfolio Update Summary & Advanced Swing Trade Entry Plans - Newser
Arrowhead Pharmaceuticals Inc. stock outlook for YEARInsider Selling & Daily Market Momentum Tracking - Newser
How to forecast Arrowhead Pharmaceuticals Inc. trends using time seriesAnalyst Upgrade & Weekly High Conviction Ideas - Newser
Analyzing net buyer seller activity in Arrowhead Pharmaceuticals Inc.Sell Signal & Free Weekly Chart Analysis and Trade Guides - Newser
Tick level data insight on Arrowhead Pharmaceuticals Inc. volatilityLong Setup & Risk Adjusted Swing Trade Ideas - Newser
What’s next for Arrowhead Pharmaceuticals Inc. stock price2025 Bull vs Bear & Risk Adjusted Buy and Sell Alerts - Newser
Long term hold vs stop loss in Arrowhead Pharmaceuticals Inc.2025 Fundamental Recap & Reliable Intraday Trade Alerts - Newser
Historical volatility pattern of Arrowhead Pharmaceuticals Inc. visualized2025 Market Sentiment & Safe Entry Zone Tips - Newser
Detecting price anomalies in Arrowhead Pharmaceuticals Inc. with AIAnalyst Upgrade & Advanced Swing Trade Entry Plans - Newser
Finanzdaten der Arrowhead Pharmaceuticals Inc-Aktie (ARWR)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.96%
1.09%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):